GlideFast Consulting Announced as the 2022 ServiceNow Elite Partner of the Year
7.2.2022 16:45:00 EET | Business Wire | Press release
GlideFast Consulting announced that it has been recognized as the 2022 ServiceNow Americas Elite Partner of the Year. GlideFast has shown their commitment to ServiceNow through industry-leading customer implementations and the ability to exhibit substantial growth.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220207005290/en/
GlideFast Consulting Announced as the 2022 ServiceNow Elite Partner of the Year (Photo: Business Wire)
The ServiceNow Global Alliances and Channel Ecosystem (ACE) organization recognizes the achievements of best-in-class partners who have contributed to ServiceNow’s growth trajectory by driving successful business outcomes for our joint customers. This year's awards are based on partner performance for 2021 by evaluating the following key attributes: revenue contribution/growth, product line expansion, workflow and skill competencies growth, and business innovation with associated digital transformation impact.
This award was presented at ServiceNow’s Americas Partner Awards digital event on Friday, February 4, 2022.
GlideFast Consulting is a consulting firm founded by ServiceNow architects and developers in 2015. Within a few years, the team quickly rose to the top of the ServiceNow Partner ecosystem as an Elite Partner by providing leading IT solutions to organizations, specifically in the telecommunications, healthcare, finance, and technology industries. Over the last few years, GlideFast has grown tremendously. They have started a ServiceNow development program called GlideFast Consulting University and acquired former ServiceNow Elite Partners, CloudPires and Pharicode.
“We are honored and humbled to receive the most prestigious award ServiceNow has to offer. Each and every GlideFast team member should be proud. It is a direct result of the above and beyond effort they give daily. On behalf of the GlideFast team, I would like to thank all of the incredible ServiceNow team members who partner with us and our loyal customers who trust us with their most strategic initiatives,” says Michael Lombardo, CEO of GlideFast Consulting.
Over the past year, ServiceNow continued to expand its global partner ecosystem by building intimate relationships with partners to support customers seeking help to navigate their digital transformation journeys and adjust to the new world of work. Membership in ServiceNow’s partner program has provided us the tools to equip, enable, and be empowered to identify jointly-aligned go-to-market initiatives and innovative offerings and solutions which deliver compelling business value for customers and accelerate growth for our ServiceNow business.
“We are grateful to be recognized by ServiceNow for our contributions. Our mission continues onward to be the unequivocal leader in the ServiceNow space. We have high expectations of ourselves and the bar has been raised once again.” says Jarred Pippy, COO of GlideFast Consulting.
GlideFast Consulting is thrilled to receive this award from ServiceNow but is still focused on growth, improvement, and expansion. This award is another example of their commitment to be the go-to partner in the ServiceNow ecosystem worldwide. The company now sets their eyes on Global Elite status as they expand globally this year.
About GlideFast Consulting
GlideFast is a ServiceNow Elite Partner and professional services firm that provides tailored solutions and professional services for ServiceNow implementations, integrations, managed support services, application development, and training. Learn more at www.glidefast.com. And connect with our team on LinkedIn at www.linkedin.com/company/glidefast.
ServiceNow, the ServiceNow logo, Now, Now Platform, and other ServiceNow marks are trademarks and/or registered trademarks of ServiceNow, Inc., in the United States and/or other countries.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220207005290/en/
Contact information
Lauren Jankowski
lauren.jankowski@glidefast.com
(908) 477-1533
www.glidefast.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 12:47:00 EEST | Press release
Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food products. Within this inspiring premise, Good Food Makers confirms itself as one of the main levers f
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 11:16:00 EEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom